The factor VIII C2 domain is essential for binding to activated platelet surfaces as well as the cofactor activity of factor VIII in blood coagulation. Inhibitory antibodies against the C2 domain commonly develop following factor VIII replacement therapy for hemophilia A patients, or they may spontaneously arise in cases of acquired hemophilia. Porcine factor VIII is an effective therapeutic for hemophilia patients with inhibitor due to its low cross-reactivity; however, the molecular basis for this behavior is poorly understood. In this study, the X-ray crystal structure of the porcine factor VIII C2 domain was determined, and superposition of the human and porcine C2 domains demonstrates that most surface-exposed differences cluster on th...
The most significant complication for patients with severe cases of congenital or acquired hemophili...
<div><p>The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatmen...
SummaryFactor VIII is a procofactor that plays a critical role in blood coagulation, and is missing ...
The factor VIII C2 domain is essential for binding to activated platelet surfaces as well as the cof...
Blood coagulation factor VIII is a glycoprotein cofactor that is essential for the intrinsic pathway...
<p>(A) Ribbon diagram presentation of the 1.7 Å X-ray crystal structure. Displayed residues are solv...
<p>(A) Comparison of human (open circles) and porcine (closed squares) factor VIII C2 domains bindin...
A deficiency in blood coagulation factor VIII (fVIII) is responsible for the inherited bleeding diso...
Blood coagulation factor VIII is a glycoprotein that binds to activated platelet membranes in the bl...
Hemophilia A is an X-linked blood disorder that results in the inability to form proper blood clots ...
Binding of factor VIII to membranes containing phosphatidyl-L-serine (Ptd-L-Ser) is mediated, in par...
Factor VIII (fVIII) is a procoagulant protein that binds to activated factor IX (fIXa) on platelet s...
The development of an immune response to infused factor VIII is a complication affecting many patien...
The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatment of man...
<p>(A) Ribbon diagram representation of the fVIII C2 domain bound to different classes of C2-specifi...
The most significant complication for patients with severe cases of congenital or acquired hemophili...
<div><p>The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatmen...
SummaryFactor VIII is a procofactor that plays a critical role in blood coagulation, and is missing ...
The factor VIII C2 domain is essential for binding to activated platelet surfaces as well as the cof...
Blood coagulation factor VIII is a glycoprotein cofactor that is essential for the intrinsic pathway...
<p>(A) Ribbon diagram presentation of the 1.7 Å X-ray crystal structure. Displayed residues are solv...
<p>(A) Comparison of human (open circles) and porcine (closed squares) factor VIII C2 domains bindin...
A deficiency in blood coagulation factor VIII (fVIII) is responsible for the inherited bleeding diso...
Blood coagulation factor VIII is a glycoprotein that binds to activated platelet membranes in the bl...
Hemophilia A is an X-linked blood disorder that results in the inability to form proper blood clots ...
Binding of factor VIII to membranes containing phosphatidyl-L-serine (Ptd-L-Ser) is mediated, in par...
Factor VIII (fVIII) is a procoagulant protein that binds to activated factor IX (fIXa) on platelet s...
The development of an immune response to infused factor VIII is a complication affecting many patien...
The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatment of man...
<p>(A) Ribbon diagram representation of the fVIII C2 domain bound to different classes of C2-specifi...
The most significant complication for patients with severe cases of congenital or acquired hemophili...
<div><p>The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatmen...
SummaryFactor VIII is a procofactor that plays a critical role in blood coagulation, and is missing ...